Moving to tolerance: Clinical application of T regulatory cells

被引：74

作者：

McMurchy, Alicia N. ^{[1
,2
]}

Bushell, Andrew ^{[3
]}

Levings, Megan K. ^{[1
,2
]}

Wood, Kathryn J. ^{[3
]}

机构：

[1] Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada

[2] Univ British Columbia, Dept Surg, Vancouver, BC V5Z 1M9, Canada

[3] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg Sci, Oxford OX3 9DU, England

来源：

SEMINARS IN IMMUNOLOGY | 2011年 / 23卷 / 04期

基金：

英国惠康基金; 英国医学研究理事会;

关键词：

Transplantation; T regulatory cells; Cellular therapy; Drug minimization; Translational medicine; CARDIAC ALLOGRAFT SURVIVAL; VERSUS-HOST-DISEASE; RENAL-TRANSPLANT TOLERANCE; LATENT TGF-BETA; EX-VIVO; IN-VITRO; FOXP3; EXPRESSION; CUTTING EDGE; SUICIDE-GENE; TREG CELLS;

D O I：

10.1016/j.smim.2011.04.001

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Decreasing the incidence of chronic rejection and reducing the need for life-long immunosuppression remain important goals in clinical transplantation. In this article, we will review how regulatory T cells (Treg) came to be recognized as an attractive way to prevent or treat allograft rejection, the ways in which Treg can be manipulated or expanded in vivo, and the potential of in vitro expanded/generated Treg for cellular therapy. We will describe the first regulatory T cell therapies that have been or are in the process of being conducted in the clinic as well as the safety concerns of such therapies and how outcomes may be measured. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：304 / 313

页数：10

共 142 条

[51] Immunoregulation in the tissues by γδ T cells [J].

Hayday, A ;

Tigelaar, R .

NATURE REVIEWS IMMUNOLOGY, 2003, 3 (03) :233-242

[52] Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion [J].

Hoffmann, Petra ;

Eder, Ruediger ;

Boeld, Tina J. ;

Doser, Kristina ;

Piseshka, Biserka ;

Andreesen, Reinhard ;

Edinger, Matthias .

BLOOD, 2006, 108 (13) :4260-4267

[53] Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation [J].

Hoffmann, Petra ;

Boeld, Tina J. ;

Eder, Ruediger ;

Huehn, Jochen ;

Floess, Stefan ;

Wieczorek, Georg ;

Olek, Sven ;

Dietmaier, Wolfgang ;

Andreesen, Reinhard ;

Edinger, Matthias .

EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (04) :1088-1097

[54] Control of regulatory T cell development by the transcription factor Foxp3 [J].

Hori, S ;

Nomura, T ;

Sakaguchi, S .

SCIENCE, 2003, 299 (5609) :1057-1061

[55] Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? [J].

Huehn, Jochen ;

Polansky, Julia K. ;

Hamann, Alf .

NATURE REVIEWS IMMUNOLOGY, 2009, 9 (02) :83-89

[56] Ex Vivo-Expanded Human Regulatory T Cells Prevent the Rejection of Skin Allografts in a Humanized Mouse Model [J].

Issa, Fadi ;

Hester, Joanna ;

Goto, Ryoichi ;

Nadig, Satish N. ;

Goodacre, Tim E. ;

Wood, Kathryn .

TRANSPLANTATION, 2010, 90 (12) :1321-1327

[57] Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery [J].

Ito, Tomoki ;

Hanabuchi, Shino ;

Wang, Yi-Hong ;

Park, Woong Ryeon ;

Arima, Kazuhiko ;

Bover, Laura ;

Qin, F. Xiao-Feng ;

Gilliet, Michel ;

Liu, Yong-Jun .

IMMUNITY, 2008, 28 (06) :870-880

[58] Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD4+25+ T cells to allow an effective graft-versus-leukemia response [J].

Jones, SC ;

Murphy, GF ;

Korngold, R .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (04) :243-256

[59] Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass [J].

Keymeulen, B. ;

Walter, M. ;

Mathieu, C. ;

Kaufman, L. ;

Gorus, F. ;

Hilbrands, R. ;

Vandemeulebroucke, E. ;

Van de Velde, U. ;

Crenier, L. ;

De Block, C. ;

Candon, S. ;

Waldmann, H. ;

Ziegler, A. G. ;

Chatenoud, L. ;

Pipeleers, D. .

DIABETOLOGIA, 2010, 53 (04) :614-623

[60] An essential role for Scurfin in CD4+CD25+ T regulatory cells [J].

Khattri, R ;

Cox, T ;

Yasayko, SA ;

Ramsdell, F .

NATURE IMMUNOLOGY, 2003, 4 (04) :337-342

← 1 2 3 4 5 6 7 8 9 10 →